BD
Medical technology company that serves healthcare institutions, life science researchers, clinical laboratories and the industry.
- Healthcare
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
* | $2.2m | Post IPO Equity | |
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (1 %) | 18 % | (7 %) | 3 % | 4 % | 8 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 23 % | 26 % | 24 % | 24 % | 26 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 5 % | 10 % | 9 % | 8 % | 8 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 6 % | 7 % | 7 % | 6 % | 6 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
BD (Becton, Dickinson and Company) is a leading global medical technology company that focuses on advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company serves a wide range of clients including hospitals, laboratories, and healthcare providers across North America, EMEA (Europe, Middle East, and Africa), Greater Asia, and Latin America. BD operates in three main segments: BD Medical, BD Life Sciences, and BD Interventional.
BD Medical focuses on medication management and delivery solutions, BD Life Sciences provides products for the safe collection and transport of diagnostic specimens, and BD Interventional offers devices for minimally invasive surgery.
The company generates revenue through the sale of medical devices, laboratory equipment, and diagnostic products. BD's business model is centered around innovation, quality, and customer service, aiming to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in healthcare settings.
Keywords: medical technology, diagnostics, healthcare, medical devices, laboratory equipment, patient outcomes, innovation, safety, efficiency, global.
Tech stack
Investments by BD
Edit
